Eugenii A. Rabiner

According to our database1, Eugenii A. Rabiner authored at least 27 papers between 2002 and 2019.

Collaborative distances:
  • Dijkstra number2 of five.
  • Erdős number3 of four.

Timeline

Legend:

Book 
In proceedings 
Article 
PhD thesis 
Dataset
Other 

Links

On csauthors.net:

Bibliography

2019
Accuracy and reliability of [<sup>11</sup>C]PBR28 specific binding estimated without the use of a reference region.
NeuroImage, 2019

2014
PET neuroimaging: The elephant unpacks his trunk: Comment on Cumming: "PET neuroimaging: The white elephant packs his trunk?".
NeuroImage, 2014

2013
Mathematical modelling of [<sup>11</sup>C]-(+)-PHNO human competition studies.
NeuroImage, 2013

2012
Identifying improved TSPO PET imaging probes through biomathematics: The impact of multiple TSPO binding sites in vivo.
NeuroImage, 2012

2011
Imaging dopamine receptors in humans with [<sup>11</sup>C]-(+)-PHNO: Dissection of D3 signal and anatomy.
NeuroImage, 2011

2010
Effect of cellular compartments on the binding of [<sup>3</sup>H](+)PhNO to the porcine D2/D3-DAR.
NeuroImage, 2010

A combined diffusion tensor imaging (DTI) and [11C]-(+)-PHNO positron emission tomography (PET) study to quantify dopamine D3/D2 receptors in pallidum.
NeuroImage, 2010

Within-subject comparison of the sensitivity of [<sup>11</sup>C]-(+)-PHNO and [<sup>11</sup>C]raclopride to amphetamine induced changes in endogenous dopamine in healthy human volunteers.
NeuroImage, 2010

A pseudo-reference region method applied to measurement of GlyT1 occupancy in human brain using [11C]GSK931145 and PET.
NeuroImage, 2010

PET imaging of dopamine D3 receptors in humans with [11C]-(+)-PHNO: dissection of PHNO signal using two highly selective D3 antagonists.
NeuroImage, 2010

Pharmacokinetic characterization of compounds with increased target residence times using PET.
NeuroImage, 2010

PET measurement of nicotine evoked dopamine release.
NeuroImage, 2010

Graphical analysis of occupancy studies for radioligands with irreversible kinetics.
NeuroImage, 2010

Evaluation of the in vivo ED<sub>50</sub> for the PET Radioligand, [<sup>11</sup>C]GSK-215083, in Papio anubis.
NeuroImage, 2010

PBR28, PBR06 and PBR111 bind two distinct TSPO sites in human brain tissue.
NeuroImage, 2010

Further validation of [<sup>11</sup>C]FLB 457 as a tool to measure prefrontal cortical DA release.
NeuroImage, 2010

Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [<sup>11</sup>C] DASB binding in the living human brain.
NeuroImage, 2010

Predicting the in vivo performance of TSPO PET radioligands using a biomathematical modelling approach.
NeuroImage, 2010

In vivo binding of antipsychotics to D3 and D2 receptors: A PET study in baboons with [11C]-(+)-PHNO.
NeuroImage, 2010

Uptake and regional distribution of [11C]rofecoxib in human brain.
NeuroImage, 2010

Association between serotonin transporter binding, physiological and environmental factors in healthy male subjects.
NeuroImage, 2010

PET evaluation of the TSPO ligands [F-18]FEPPA, [F-18]PRB06, and [F-18]PBR111 in nonhuman primate.
NeuroImage, 2010

Awake nonhuman primate brain PET imaging without head restraint.
NeuroImage, 2010

Differentiation of the Mu-opioid ligand GSK1521498 from naltrexone using [11C]carfentanil PET and fMRI.
NeuroImage, 2010

Effect of amphetamine on mouse striatal binding of [<sup>11</sup>C]Raclopride using the Inveon small animal PET scanner.
NeuroImage, 2010

GSK588045 occupancy of brain 5-HT1A receptors examined using [11C]WAY100635 PET.
NeuroImage, 2010

2002
A Database of [<sup>11</sup>C]WAY-100635 Binding to 5-HT<sub>1A</sub> Receptors in Normal Male Volunteers: Normative Data and Relationship to Methodological, Demographic, Physiological, and Behavioral Variables.
NeuroImage, 2002


  Loading...